Ardelyx reported $148.62M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Abbott USD 52.06B 69M Mar/2026
Amgen USD 11.69B 2.5B Jun/2026
Ardelyx USD 148.62M 18.33M Mar/2026
aTyr Pharma USD 48.79M 9.15M Jun/2026
Corcept Therapeutics USD 705.78M 67.79M Jun/2026
Curis USD 12.71M 7.24M Mar/2026
Sanofi EUR 73.14B 1.43B Mar/2026
TG Therapeutics USD 604.08M 20.95M Jun/2026
United Therapeutics USD 6.4B 499.2M Jun/2026